Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 6/20 | 1.00 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 1.00 |
| ▸ | ESR1 | P03372 | 4/20 | 1.00 |
| ▸ | NQO2 | P16083 | 4/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 3/20 | 1.00 |
| ▸ | AHR | P35869 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 3/20 | 1.00 |
| ▸ | ABL1 | P00519 | 2/20 | 1.00 |
| ▸ | TTR | P02766 | 2/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 2/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 2/20 | 1.00 |
| ▸ | BCR | P11274 | 2/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 2/20 | 1.00 |
| ▸ | TUBB1 | Q9H4B7 | 2/20 | 1.00 |
| ▸ | TUBB4A | P04350 | 1/20 | 1.00 |
| ▸ | TUBB | P07437 | 1/20 | 1.00 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 1.00 |
| ▸ | TUBA1B | P68363 | 1/20 | 1.00 |
| ▸ | TUBA4A | P68366 | 1/20 | 1.00 |
| ▸ | TUBB4B | P68371 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trismethoxyresveratrol SCHEMBL918740 | 1.00 | CYP1A1 (1.00) | CYP1A1CYP1B1ESR1NQO2PTGS2 | |
| 8Z-3,4',5-Trimethoxystilbene SCHEMBL1006207 | 1.00 | CYP1A1 (1.00) | CYP1A1CYP1B1ESR1NQO2PTGS2 | |
| SCHEMBL13443549 | 0.95 | CYP1A1 (0.91) | CYP1A1CYP1B1ESR1NQO2PTGS2 | |
| SCHEMBL3758141 | 0.95 | CYP1A1 (0.91) | CYP1A1CYP1B1ESR1NQO2PTGS2 | |
| SCHEMBL5809462 | 0.91 | CYP1A1 (0.84) | CYP1A1CYP1B1ESR1NQO2PTGS2 | |
| SCHEMBL5809455 | 0.91 | CYP1A1 (0.84) | CYP1A1CYP1B1ESR1NQO2PTGS2 | |
| SCHEMBL9177232 | 0.91 | TUBB1 (0.83) | CYP1A1CYP1B1ESR1NQO2PTGS2 | |
| SCHEMBL13790336 | 0.88 | RELA (0.81) | CYP1A1CYP1B1ESR1NQO2PTGS2 | |
| SCHEMBL1743365 | 0.88 | CYP1A1 (1.00) | CYP1A1CYP1B1ESR1NQO2PTGS2 | |
| SCHEMBL4881152 | 0.88 | RELA (0.81) | CYP1A1CYP1B1ESR1NQO2PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 447 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720332-A1 | METHODS AND PROBES FOR DETECTING POLYNUCLEOTIDE SEQUENCES IN CELLS AND TISSUES | Singular Genomics Systems, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| WO-2024258363-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | SAHIN FIKRET (TR) | 2024-12-19 | — | — | WO | claimed |
| WO-2024249961-A1 | METHODS AND PROBES FOR DETECTING POLYNUCLEOTIDE SEQUENCES IN CELLS AND TISSUES | Singular Genomics Systems, Inc. (US) | 2024-12-05 | — | — | WO | claimed |
| CN-118860331-A | Method for processing input parameters, device for carrying out the method, computing device and application | 罗伯特·博世有限公司 | 2024-10-29 | — | — | CN | claimed |
| CN-118672547-A | Method, device, computing device and use for processing input variables by means of a processing device having at least one transistor | 罗伯特·博世有限公司 | 2024-09-20 | — | — | CN | claimed |
| EP-3509115-B1 | PHOTOVOLTAIC DEVICE | NISSAN MOTOR (JP) | 2024-09-11 | — | — | EP | claimed |
| CN-220734397-U | Solar energy and air conditioner auxiliary energy-saving system | 江苏宜富思特空调有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-116790770-A | CDA primer set and kit for detecting mycobacterium tuberculosis and application of CDA primer set and kit | 中国科学院大学宁波华美医院 | 2023-09-22 | — | — | CN | claimed |
| CN-108250046-B | Synthesis method of resveratrol | 上海巧坤化工科技有限公司 | 2023-09-15 | — | — | CN | claimed |
| US-20100048577-A1 | Method for treating benign prostate hyperplasia using resveratrol | NEW YORK INSTITUTE OF TECHNOLOGY | 2010-02-25 | — | — | US | claimed |
| WO-2009012551-A1 | RESVERATROL COMPLEX AND PROCESS FOR THE PREPERATION | UNIÄO BRASILEIRA DE EDUCAÇAO E ASSITENCIA-MANTENEDORA DA PUCRS (BR) | 2009-01-29 | — | — | WO | claimed |
| EP-1654210-B1 | STILBENE DERIVATIVES AND THEIR USE IN MEDICAMENTS | SZEKERES THOMAS (AT) | 2008-07-30 | — | — | EP | claimed |
| US-20080166304-A1 | Inactivation of Microorganisms With Multidrug Resistance Inhibitors and Phenothiaziniums | THE GENERAL HOSPITAL CORPOARTION (US) | 2008-07-10 | — | — | US | claimed |
| US-20080139650-A1 | Fungicidally Active Polymer Dispersions And Use Thereof | CELANESE EMULSIONS GMBH (DE) | 2008-06-12 | — | — | US | claimed |
| WO-2008070872-A1 | PREVENTION AND TREATMENT OF COLON CANCER | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2008-06-12 | — | — | WO | claimed |
| WO-2006034219-A2 | INACTIVATION OF MICROORGANISMS WITH MULTIDRUG RESISTANCE INHIBITORS AND PHENOTHIAZINIUMS | THE GENERAL HOSPITAL CORPORATION (US) | 2006-03-30 | — | — | WO | claimed |
| WO-2003031381-A2 | SYNTHESIS OF (Z)-3,5,4'-TRIMETHOXYSTILBENE, AND USE THEREOF | UNIVERSITE LOUIS PASTEUR (FR) | 2003-04-17 | — | — | WO | claimed |
| US-20020028852-A1 | Resveratrol analogs for prevention of disease | RUTGERS, THE STATE UNIVERSITY | 2002-03-07 | — | — | US | claimed |
| WO-2001021165-A1 | RESVERATROL ANALOGS FOR PREVENTION OF DISEASE | RUTGERS, THE STATE UNIVERSITY (US) | 2001-03-29 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048577-A1 | Method for treating benign prostate hyperplasia using resveratrol | PPARA, PPARG, NCOA3 | CYP1A1 1623/4885CYP1B1 1807/4885ESR1 284/4885 |
| US-20080139650-A1 | Fungicidally Active Polymer Dispersions And Use Thereof | CBR3, CBR1, CYP3A4 | CYP1A1 5/4885CYP1B1 4/4885ESR1 980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.